Patent · US Active

Anti-sigmas for programmable transcriptional regulation

US10030320B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignees

Massachusetts Institute of Technology · US
The Regents of the University of California · US

Inventors

Virgil Rhodius · El Sobrante, US
Christopher A. Voigt · Oakland, US
Carol Gross · Berkeley, US

Key dates

Filing date	Mar 15, 2013
Grant date	Jul 24, 2018
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG16C20/60
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to anti-sigma factors (“anti-sigmas”) that bind to sigma factors and block activation of transcription. Anti-sigmas and their cognate sigma factors provide a highly effective mechanism for regulating gene expression in genetic circuits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.